frame lens: A randomized block group design was used to randomly assign the included study subjects. The appropriate randomization number and random allocation scheme will be given after enrollment.
Study summary
To confirm the efficacy of DIMS lenses in controlling myopia progression, we planned a prospective, single-centre, randomised, double-blind, controlled, non-inferiority clinical study.
Eligibility
Sex
ALL
Min age
8 Years
Max age
13 Years
Healthy volunteers
Accepted
Inclusion Criteria:
* The subjects had spherical RE of -1.00 to -6.00 D, astigmatism ≤ 1.50 D, anisometropia ≤ 1.50 D
* the best corrected visual acuity in the left and right eyes subjective optometry is greater than or equal to 1.0
Exclusion Criteria:
* Candidate subjects were excluded from the study if they had strabismus, ocular limitations, or systemic abnormalities affecting vision and ocular motility
Primary outcome measure(s)
Cycloplegic objective refraction — 12 months Cycloplegic objective refraction was measured with an autorefractor (Topcon KR8900, Japan)
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.